Loading...
XHKG
2273
Market cap1.06bUSD
Jul 18, Last price  
35.45HKD
1D
-0.70%
1Q
16.42%
IPO
22.03%
Name

Gushengtang Holdings Ltd

Chart & Performance

D1W1MN
No data to show
P/E
24.73
P/S
2.51
EPS
1.31
Div Yield, %
0.37%
Shrs. gr., 5y
1.73%
Rev. gr., 5y
27.52%
Revenues
3.02b
+30.09%
726,245,000896,156,000925,366,0001,372,099,0001,624,561,0002,323,351,0003,022,377,000
Net income
307m
+21.64%
-172,981,000-148,020,000-255,749,000-507,069,000180,854,000252,202,000306,780,000
CFO
0k
-100.00%
30,785,000132,254,000154,904,000187,755,000280,995,000410,142,0000
Dividend
Jun 24, 20250.41 HKD/sh

Profile

Gushengtang Holdings Limited, an investment holding company, provides healthcare services and sells healthcare products. It also engages in the wholesale and retail of pharmaceutical products; and provision of investment management and supply chain management services. The company was formerly known as Gushengtang (Cayman) Ltd. and changed its name to Gushengtang Holdings Limited in September 2021. The company was incorporated in 2014 and is headquartered in Guangzhou, China.
IPO date
Dec 10, 2021
Employees
2,155
Domiciled in
CN
Incorporated in
KY

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑12
Income
Revenues
3,022,377
30.09%
2,323,351
43.01%
1,624,561
18.40%
Cost of revenue
2,666,408
2,059,428
1,428,524
Unusual Expense (Income)
NOPBT
355,969
263,923
196,037
NOPBT Margin
11.78%
11.36%
12.07%
Operating Taxes
56,101
31,232
15,158
Tax Rate
15.76%
11.83%
7.73%
NOPAT
299,868
232,691
180,879
Net income
306,780
21.64%
252,202
39.45%
180,854
-135.67%
Dividends
(89,763)
Dividend yield
0.73%
Proceeds from repurchase of equity
411,884
(40,242)
BB yield
-3.35%
0.33%
Debt
Debt current
88,387
93,274
75,632
Long-term debt
828,651
631,446
333,073
Deferred revenue
38,745
Other long-term liabilities
96,344
87,734
(52,957)
Net debt
(331,625)
(580,987)
(621,706)
Cash flow
Cash from operating activities
410,142
280,995
CAPEX
(76,436)
(36,971)
Cash from investing activities
(263,609)
(178,364)
Cash from financing activities
157,501
(138,079)
FCF
211,517
128,570
154,493
Balance
Cash
1,148,895
1,331,614
1,024,342
Long term investments
99,768
(25,907)
6,069
Excess cash
1,097,544
1,189,539
949,183
Stockholders' equity
2,533,307
(1,413,262)
(1,364,521)
Invested Capital
1,883,653
4,177,653
3,475,458
ROIC
9.89%
6.08%
5.21%
ROCE
11.94%
9.55%
9.24%
EV
Common stock shares outstanding
251,016
244,234
239,050
Price
33.80
-32.94%
50.40
-0.20%
50.50
43.06%
Market cap
8,484,341
-31.07%
12,309,393
1.97%
12,072,019
195.44%
EV
8,153,088
11,729,491
11,451,381
EBITDA
355,969
384,079
299,726
EV/EBITDA
22.90
30.54
38.21
Interest
25,576
17,615
Interest/NOPBT
9.69%
8.99%